Dergiler / Organic Communications / 2019 / Cilt: 12 - Sayı: 3

Synthesis and engineering of sodium alginate/inulincore-shell nano-hydrogels for controlled-release oral delivery of 5-ASA

Sayfa
132–142
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Ideal slow release of 5-ASA was obtainedwith thefrom spherical particleshavingcoreandshellsizesof 84-100 and 156-198 nm, respectively.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Protectionof drug molecules fromdigestive enzymes and providing their controlled release at the site of intestinal inflammationarethe most important aims of oral nano drug delivery systems (NDDSs).Encapsulation and controlled release of 5-aminosalicylic acid (5-ASA), which is a well-known anti-inflammatory drug, for effective treatment of Crohn’s disease, ulcerative colitis and inflammatory bowel disease (IBD)wereaimed in this study.
📊
Temel Bulgular & Veri:For the preparation of core-shell structured NDDSs, 5-ASA loaded sodium alginate (Na-Alg) coreswith negative surface charge were prepared by calcium chloride crosslinking of Na-Alg and subsequentlycoatingwith quaternized inulin (QIn) viaCoulomb interaction.
💡
Sonuç & Katkı:Ideal slow release of 5-ASA was obtainedwith thefrom spherical particleshavingcoreandshellsizesof 84-100 and 156-198 nm, respectively.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Protectionof drug molecules fromdigestive enzymes and providing their controlled release at the site of intestinal inflammationarethe most important aims of oral nano drug delivery systems (NDDSs).Encapsulation and controlled release of 5-aminosalicylic acid (5-ASA), which is a well-known anti-inflammatory drug, for effective treatment of Crohn’s disease, ulcerative colitis and inflammatory bowel disease (IBD)wereaimed in this study. For the preparation of core-shell structured NDDSs, 5-ASA loaded sodium alginate (Na-Alg) coreswith negative surface charge were prepared by calcium chloride crosslinking of Na-Alg and subsequentlycoatingwith quaternized inulin (QIn) viaCoulomb interaction. As a shell layer, QIn was separately synthesized by quaternization of inulinwith glycidyl trimethylammonium chloride (GTMAC). While the crosslinked Na-Alg core is responsible fortheprotection of 5-ASA from acidic pH in stomach, quaternized inulin shell, known to be highlymucoadhesive, was implemented for digestion by the intestinal flora providing controlled release of 5-ASA at inflammation site of small and/or large intestine.Characterization of NDDSs was carried out using GPC, FT-IR, 1H-NMR and SEMtechniques. Ideal slow release of 5-ASA was obtainedwith thefrom spherical particleshavingcoreandshellsizesof 84-100 and 156-198 nm, respectively.

🔖

Bu Makaleye Atıf Yap

BAHADORİ, F., AKİNAN, B. S., AKYİL, S., EROGLU, M. S. (2019). Synthesis and engineering of sodium alginate/inulincore-shell nano-hydrogels for controlled-release oral delivery of 5-ASA. Organic Communications, Cilt: 12 - Sayı: 3, 132–142. https://ajindex.com/articles/288461

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Ensign, L.M.; Cone, R.; Hanes, J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv. Drug Deliv. Rev.2012,64(6), 557-570. [2]Reinholz, J.; Landfester, K.; Mailänder, V. The challenges of oral drug delivery via nanocarriers. Drug Del.2018,25(1),1694-1705. [3]Zhang, T.; Zhu, G.; Lu, B.; Peng, Q. Oral nano-delivery systems for colon targeting therapy. Pharm. Nanotechnol.2017,5(2),83-94. [4]Hua, S.; Marks, E.; Schneider, J.J.; Keely, S. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomedicine: NBM. 2015,11(5),1117-1132. [5]Bernstein, C.N.; Eaden, J.; Steinhart, A.H.; Munkholm, P.; Gordon, P.H. Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid. Inflamm. Bowel Dis.2002,8(5),356-361.[ 6]Mladenovska, K.; Raicki, R.; Janevik, E.; Ristoski, T.; Pavlova, M.; Kavrakovski, Z.; Dodov, M.; Goracinova, K. Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles. Int. J. Pharm.2007,342(1-2),124-136. [7]Loftus Jr, E.; Kane, S.; Bjorkman, D. Short‐term adverse effects of 5‐aminosalicylic acid agents in the treatment of ulcerative colitis. Alıment. Pharm. Ther.2004,19(2),179-189. [8]De, S.; Robinson, D. Polymer relationships during preparation of chitosan–alginate and poly-l-lysine–alginatenanospheres. J. Control. Release. 2003,89(1),101-112. [9]Bodmeier, R.; Wang, J. Microencapsulation of drugs with aqueous colloidal polymer dispersions. J. Pharm. Sci. 1993,82(2),191-194. [10]Tu, J.; Mahalingam, R.; Jasti, B.; Li, X. Polymers in Oral Modified Release Systems. InOral Controlled Release Formulation Design and Drug Delivery from Theory to Practice.Wen, H.; Park, K.,Wiley, Singapore, 2011 [11]Sahiner, N.; Sagbas, S.; Yoshida, H.; Lyon, L.A. Synthesis and properties of inulin based microgels. J. Colloid Interf.Sci. 2014,2,15-18. [12]Zhang, L.; Li, Y.; Wang, C.; Li, G.; Zhao, Y.; Yang, Y. Synthesis of methylprednisolone loaded ibuprofen modified inulin based nanoparticles and their application for drug delivery. Mat. Sci. Eng. C-Mater.2014,42,111-115. [13]Scialabba, C.; Licciardi, M.; Mauro, N.; Rocco, F.; Ceruti, M.; Giammona, G. Inulin-based polymer coated SPIONs as potential drug delivery systems for targeted cancer therapy. Eur. J. Pharm. Biopharm.2014,88(3),695-705. [14]Mensink, M.A.; Frijlink, H.W.; van der Voort Maarschalk, K.; H